ArticleAnnals of dermatology2023

Refractory Bullous Pemphigoid Successfully Treated with Reslizumab: A Possible Novel Therapeutic Modality.

Hyeok-Jin Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.